Skip to main content

Table 1 Cytokine levels (pg/ml) pre and post-rhIL-12 infusion

From: Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma

Accession Number

Sampling Timepoint

Sample ID

Results (pg/ml)

   

TNF-α

IL-12 p70

INF-γ

VEGF

IL-10

IL-8

IP-10

5

Baseline

1

15.3

6.7

< 0.78

< 2.30

5.9

38.6

7.6

 

6 Hr

2

16.1

4973.2

1.9

56.4

18.8

270.0

191.6

 

24 Hr

3

15.7

4722.9

38.1

33.8

35.2

72.7

263.8

 

48 Hr

4

18.7

8004.8

215.9

74.1

80.5

213.1

303.8

 

Baseline

5

105.4

7.6

1.0

36.4

36.5

190.0

12.9

 

6 Hr

6

34.6

11040.0

140.1

348.8

3686.9

1254.7

460.2

 

24 Hr

28

70.1

3789.5

232.5

238.8

553.0

3897.2

367.2

 

48 Hr

7

43.4

1085.4

198.9

178.8

187.1

6363.6

354.0

11

Baseline

8

16.1

7.1

< 0.78

48.4

18.4

67.7

7.9

 

6 Hr

9

17.4

5380.8

< 0.78

69.7

39.9

122.8

251.2

 

24 Hr

10

74.1

5217.5

56.8

87.3

72.2

876.7

354.3

 

48 Hr

11

48.0

934.2

220.0

82.6

30.1

128.0

1153.9

10

Baseline

12

16.6

6.1

1.0

89.5

5.5

231.7

7.9

 

6 Hr

13

55.2

25700.0

37.7

447.5

296.5

1577.8

351.3

 

24 Hr

14

185.3

6580.7

236.3

428.0

90.7

1538.3

429.6

 

48 Hr

15

56.0

561.2

155.3

379.3

27.3

2923.8

355.6

4

Baseline

20

15.3

6.4

< 0.78

< 2.30

3.6

7.2

< 0.95

 

6 Hr

21

16.1

5937.5

2.2

82.8

4.8

251.3

238.2

 

24 Hr

22

17.4

5547.5

74.8

69.4

9.7

93.2

258.2

 

48 Hr

23

35.1

4283.1

504.3

55.7

27.3

124.7

275.7

3

Baseline

24

17.4

8.7

10.0

110.3

10.4

492.4

9.0

 

6 Hr

25

17.4

10214.7

19.5

213.7

15.8

1711.3

229.7

 

24 Hr

26

40.6

4103.6

184.2

187.9

19.9

3348.5

223.9

 

48 Hr

27

16.6

30.7

108.8

37.7

3.6

475.5

202.0